Label: ANTICOAGULANT SODIUM CITRATE- trisodium citrate dihydrate solution

Anticoagulant Sodium Citrate 4% w/v Solution, USP is intended for use only with automated apheresis devices.

The pouch is a moisture barrier. Do not remove from pouch until ready to use. Do not use unless solution is clear and no leaks detected. Do not use unless port protector is in place.

Anticoagulant Sodium Citrate 4% w/v Solution, USP in the 250 mL single dose container is a sterile solution that contains 4g Sodium Citrate Dihydrate, USP per 100 mL, pH adjusted with citric acid.

Not for direct intravenous infusion.

Anticoagulant Sodium Citrate 4% w/v Solution, USP is a clear solution supplied in sterile and nonpyrogenic PVC bags per carton.

LOT

EXP

2B7867
NDC 0338-9669-01

Anticoagulant
Sodium Citrate
4% w/v
Solution USP

Rx only

250 mL EACH 100 mL CONTAINS 4 g SODIUM
CITRATE (DIHYDRATE) USP
pH ADJUSTED WITH CITRIC ACID
STERILE NONPYROGENIC
INTENDED FOR USE ONLY WITH AUTOMATED APHERESIS
DEVICES
CAUTION — NOT FOR DIRECT INTRAVENOUS INFUSION THE
POUCH IS A MOISTURE BARRIER DO NOT USE UNLESS
SOLUTION IS CLEAR SQUEEZE AND INSPECT INNER BAG
WHICH MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS
ARE FOUND SINGLE USE CONTAINER DISCARD UNUSED
PORTION DIRECTIONS FOR USE ARE CONTAINED IN THE
OWNERS OPERATING AND MAINTENANCE MANUAL OF THE
APHERESIS MACHINE TO BE USED

RECOMMENDED STORAGE
ROOM TEMPERATURE (25C/77F) AVOID EXCESSIVE HEAT
PROTECT FROM FREEZING.

FOR PRODUCT INFORMATION 1-800-933-0303

BAXTER IS A TRADEMARK OF BAXTER INTERNATIONAL

Baxter Logo
BAXTER HEALTHCARE CORPORATION
DEERFIELD IL 60015 USA

MADE IN USA

07-25-00-4675